Crescent Biopharma CBIO
NASDAQ CBIO
$14.59 -0.17 (-1.15%)
At close: Sep 30, 2026 · 4:00 PM EDT

Crescent Biopharma (CBIO) Other Non-Current Assets (2014 - 2026)

Updated

Crescent Biopharma's Other Non-Current Assets came in at $1.5 million for Q2 2026, compared with $106,000 a year earlier and up 29.2% from the prior quarter.

Analysis

Crescent Biopharma (CBIO) Other Non-Current Assets (2014 - 2026) Analysis & Trends

At the end of FY2025, Crescent Biopharma's Other Non-Current Assets was $1.22 million, up 49.6% from FY2024.

  • Other Non-Current Assets has increased in each of the last three years, though with a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Assets was $813,000 in FY2024 (+34.7%), $603,737 in FY2023 (+104.9%), $294,710 in FY2022 (-81.1%) and $1.56 million in FY2021 (unchanged).
  • The Q2 2026 figure represents the highest quarterly Other Non-Current Assets since Q2 2022.
  • Year-over-year, Other Non-Current Assets increased in two of the last four quarters, with growth averaging 15.4%.
  • The fastest year-over-year change in Other Non-Current Assets over five years came in Q1 2024 (growth of 267.5%), and the weakest in Q1 2023 (a decline of 97.6%).
  • Business Quant data shows CBIO's Other Non-Current Assets at $1.16 million (Q1 2026), $1.22 million (Q4 2025) and $1.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Crescent Biopharma 404.96 Mn -302.33 Mn - 1.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.50 Mn
Mar 31, 2026 1.16 Mn
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.25 Mn
Jun 30, 2025 106,000.00
Dec 31, 2024 813,000.00
Sep 30, 2024 52,320.00
Jun 30, 2024 137,105.00
Mar 31, 2024 192,268.00
Dec 31, 2023 603,737.00
Sep 30, 2023 52,320.00
Jun 30, 2023 52,320.00
Mar 31, 2023 52,320.00
Dec 31, 2022 294,710.00
Sep 30, 2022 807,800.00
Jun 30, 2022 2.22 Mn
Mar 31, 2022 2.22 Mn
Dec 31, 2021 1.56 Mn
Sep 30, 2021 1.56 Mn
Jun 30, 2021 1.56 Mn
API Access

Crescent Biopharma Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=CBIO&period=max&api_key=YOUR_API_KEY